Tech Company Financing Transactions
M3 Biotechnology Funding Round
Alzheimer's Drug Discovery Foundation joined a $1.4 million funding round for M3 Biotechnology. The financing was announced on 4/17/2017.
Transaction Overview
Company Name
Announced On
4/17/2017
Transaction Type
Venture Equity
Amount
$1,400,000
Round
Undisclosed
Investors
Alzheimer's Drug Discovery Foundation (Howard Fillit)
Proceeds Purpose
The fund makes early stage investments in the most promising Alzheimer's-specific therapeutics which require funding for the critical phase of translating successful animal therapies to human clinical trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4000 Mason Rd. Box 352141 300
Seattle, WA 98195
USA
Seattle, WA 98195
USA
Phone
Website
Email Address
Overview
M3 Biotechnology is a therapeutics company with a novel platform of disease-modifying regenerative small molecules, particularly relevant to neurodegenerative diseases like Alzheimer's.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Leen Kawas
Chief Financial Officer
Glenna Mileson
Browse more venture capital transactions:
Prev: 4/17/2017: TheWaveVR venture capital transaction
Next: 4/18/2017: Gravity Supply Chain venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs